100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Metronidazole is prescribed to treat the following conditions:
Metronidazole is an antibacterial medication that belongs to the imidazole class and is used as an antiprotozoal agent. Anaerobes decrease the 5-nitro group of Metronidazole metabolically. Metronidazole's bactericidal action is due to the reduced form of the drug interacting with DNA, according to studies.
Tablet and Suspension:
Trichomoniasis (Adults & Children over 10 yrs)-
Trichomoniasis (Children)-
Intestinal amoebiasis (Adults & Children over 10 yrs)-
Intestinal amoebiasis (Children)-
Extra-intestinal & Asymptomatic amoebiasis (Adults & Children over 10 yrs)-
Extra-intestinal & Asymptomatic amoebiasis (Children)-
Giardiasis (Adults & Children over 10 yrs)-
Giardiasis (Children)-
Acute ulcerative gingivitis (Adults & Children over 10 yrs)-
Acute ulcerative gingivitis (Children)-
Acute dental infections (Adults & Children over 10 yrs)-
Bacterial Vaginosis (Adults & Children over 10 yrs)-
Leg ulcers and pressure sores (Adults & Children over 10 yrs)-
Anaerobic infections (Adults & Children over 10 yrs)-
Anaerobic infections (Children)-
Surgical prophylaxis (Adults & Children over 10 yrs)-
Surgical prophylaxis (Children)-
Vaginal Gel:
The recommended dose is one applicator full of Metronidazole gel (approximately 5 grams containing approximately 37.5 mg of Metronidazole) intravaginally once or twice a day for 5 days. For once a day dosing, Metronidazole gel should be administered at bedtime.
Suppository:
Anaerobic Infections-
Surgical Prophylaxis-
IV Infusion:
Metronidazole intravenous infusion requires no dilution and should not be mixed with any other drugs prior to administration.
Disulfiram: Patients using metronidazole and disulfiram at the same time have experienced psychotic responses.
Because of the risk of a disulfiram-like (antabuse effect) reaction, alcoholic beverages and medications containing alcohol should be avoided during therapy and for at least one day following (flushing, vomiting, tachycardia). Warfarin-type oral anticoagulant therapy: Reduced hepatic catabolism causes potentiation of the anticoagulant action and increased hemorrhagic risk. During metronidazole medication, prothrombin time should be evaluated more regularly and anticoagulant therapy altered if co-administration is used. Metronidazole can raise lithium levels in the bloodstream.
When co-administration of cyclosporin and creatinine is required, serum cyclosporin and serum creatinine should be regularly monitored.
Metronidazole elimination is accelerated with phenytoin or phenobarbital, resulting in lower plasma levels.
5-Fluorouracil: A decrease in 5-fluorouracil clearance leads to an increase in 5-fluorouracil toxicity.
Busulfan: Metronidazole can raise busulfan levels in the blood, resulting in severe busulfan toxicity.
Patients having a history of hypersensitivity to Metronidazole or other Nitroimidazole derivatives should avoid taking it.
During treatment, metallic taste, nausea, vomiting, diarrhoea, sleepiness, and rashes may occur.
Metronidazole is classified as a pregnancy category B by the US Food and Drug Administration. However, no suitable and well-controlled studies in pregnant women have been conducted. Because animal reproduction studies do not always predict human response, this medication should only be used during pregnancy if absolutely necessary. Human milk has been found to contain metronidazole. When Metronidazole is given to a breastfeeding mother, caution should be observed.
If metronidazole must be given for a longer period of time than is generally indicated, it is recommended that hematological tests, particularly leucocyte counts, be performed on a regular basis and that patients be watched for adverse responses such as peripheral or central neuropathy (such as paresthesia, ataxia, dizziness, convulsive seizures). Patients with hepatic encephalopathy should be given metronidazole with caution. Metronidazole might cause urine to discolor, thus patients should be cautioned.
Anti-diarrhoeal Antiprotozoal Amoebicides
Keep it below 30°C. Protect yourself from the sun. Medicines should be kept out of the reach of youngsters. Do not use after the expiration date.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.